Sichuan, China

Liang Xiao

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 9.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Sichuan, CN (2019 - 2024)
  • Chengdu, CN (2021 - 2024)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Innovations and Contributions of Inventor Liang Xiao

Introduction

Liang Xiao is a prominent inventor based in Sichuan, China, known for his significant contributions to the field of biopharmaceuticals. With a total of 11 patents to his name, he has made remarkable advancements in therapeutic monoclonal antibodies.

Latest Patents

One of his latest patents is titled "Antibody and use thereof." This invention provides an anti-CLDN18.2 antibody or an antigen-binding fragment, along with nucleic acid molecules for encoding the antibody and fragment. The anti-CLDN18.2 antibody exhibits high specificity and affinity to CLDN18.2, effectively binding to it and mediating the killing of CLDN18.2 expressing cells. Additionally, this patent includes a pharmaceutical composition comprising the antibody or fragment, which can be utilized in the preparation of drugs for the prevention and treatment of tumors. Another significant patent is the "Anti-FXI/FXIa antibody and use thereof." This invention relates to therapeutic monoclonal antibodies and provides an anti-FXI/FXIa antibody or an antigen-binding fragment, along with nucleic acid molecules encoding the same. The anti-FXI/FXIa antibody demonstrates specificity and high affinity to FXI/FXIa, effectively inhibiting its activity. This patent also includes a pharmaceutical composition for the prevention and treatment of diseases related to coagulation or thromboembolism.

Career Highlights

Liang Xiao has worked with notable companies such as Sichuan Kelun Biotech Biopharmaceutical Co., Ltd. and Klus Pharma Inc. His work in these organizations has contributed to the development of innovative biopharmaceutical solutions.

Collaborations

Liang has collaborated with talented individuals in his field, including Tongtong Xue and Jingyi Wang. These collaborations have further enhanced his research and development efforts.

Conclusion

Liang Xiao's innovative work in the field of biopharmaceuticals, particularly in the development of therapeutic antibodies, showcases his significant contributions to medical science. His patents reflect a commitment to advancing healthcare solutions and improving treatment options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…